Jyothy Labs initiates arbitration over Pril and Fa brand exit

2 min read     Updated on 23 Jun 2026, 03:24 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Jyothy Labs has initiated arbitration at the Singapore International Arbitration Center concerning the exit of the Pril and Fa brands following the non-renewal of license agreements by Henkel AG & Co. KGaA. The company ceased operations for these brands on June 1, 2026, and is pursuing legal remedies to address valuation and transition matters. Pril contributed approximately 7% to 8% of total revenue, and the company expects a near-term impact on margins, focusing on scaling its Exo brand and launching new products to mitigate the loss.

powered bylight_fuzz_icon
43084048

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited has initiated arbitration at the Singapore International Arbitration Center to assert its contractual rights regarding the exit and transition mechanism for the Pril and Fa brands. This follows the company's decision to stop manufacturing, marketing, selling, and distributing these brands effective June 1, 2026, after Henkel AG & Co. KGaA communicated it would not renew the license agreements expiring on May 31, 2026. The company is pursuing legal remedies to address the end-of-term consequences, including business transfer, valuation consideration, and associated transition matters.

Agreement and Dispute Background

The License Agreements and Technology License Agreements were executed on May 31, 2011, between Erstwhile Henkel India Limited—which amalgamated with Jyothy Labs Limited—and Henkel AG & Co. KGaA. These agreements covered the manufacturing, distribution, marketing, and sale of products under the Pril and Fa brands. While commercial discussions were held for several months to explore revised terms and operational alternatives, they concluded without a mutually acceptable framework for continuation. Consequently, the company has resorted to the agreed dispute resolution process to protect its interests and those of its stakeholders.

Sr. No Particulars Details
A Name of parties to the Agreement Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA
B Nature of the Agreement License Agreements and Technology License Agreements for manufacturing, distribution, marketing and sale under Pril and Fa brands
C Date of execution of the Agreement May 31, 2011
D Details of termination and impact Company initiated arbitration at Singapore International Arbitration Center to assert contractual rights on exit and transition mechanism

Strategic Response and Financial Impact

Pril contributed approximately 7% to 8% of the company's total revenue, estimated broadly between ₹225 crore and ₹240 crore. Its exit will result in a near-term impact on the revenue mix and margins, with FY 2027 expected to be a transition year for the Dishwash Liquids segment. To mitigate this, Jyothy Labs is scaling up Exo Dishwash Liquid, a brand it has held since 2005-2006, which will now serve as the anchor for the company's dishwash franchise across formats. The company stated that manufacturing facilities are multiproduct and flexible, allowing for capacity redeployment without material stranded exposure. Additionally, new product developments (NPDs) across categories are planned to cover the revenue gap.

Regulatory Disclosure

The transcript of the conference call held on June 18, 2026, was submitted to BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreyas Parag Trivedi, Head – Legal & Company Secretary, signed the disclosure on behalf of the company. Jyothy Labs confirmed that other Henkel brands, such as Henko and Mr. White, operate under perpetual license arrangements with no royalty obligations and are not affected by this development.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+0.36%-1.90%-18.25%-41.72%+15.35%

What is the expected timeline for the Singapore International Arbitration Center to reach a resolution?

How much market share can Exo Dishwash Liquid realistically capture to offset the loss of the Pril brand?

What specific new product developments (NPDs) will be prioritized to fill the projected ₹240 crore revenue gap?

Jyothy Labs sets July 14 date for 35th AGM

1 min read     Updated on 21 Jun 2026, 02:42 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Jyothy Labs Limited has announced its 35th Annual General Meeting for July 14, 2026, to be held via Video Conferencing and Other Audio Visual Means. The meeting will consider a final dividend of ₹3.50 per equity share for FY26, with a record date of June 29, 2026. The agenda includes the adoption of audited financial statements, re-appointment of directors, and ratification of auditor remuneration. Remote e-voting is available from July 11 to July 13, 2026.

powered bylight_fuzz_icon
43404865

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited has scheduled its 35th Annual General Meeting for Tuesday, July 14, 2026, at 11:30 A.M. IST, conducted through Video Conferencing and Other Audio Visual Means (OAVM). The meeting will consider the declaration of a final dividend of ₹3.50 per equity share for the financial year 2025-26, subject to shareholder approval. The record date for determining dividend eligibility is Monday, June 29, 2026.

The agenda includes the adoption of audited financial statements for the year ended March 31, 2026, and the re-appointment of Mr. Ravi Razdan, Director-IT & HR. Shareholders will also vote on the ratification of remuneration for cost auditors M/s. R. Nanabhoy & Co. at ₹5,10,000 for FY27, plus applicable taxes. A special resolution proposes the re-appointment of Mr. Aditya Sapru as an Independent Director for a five-year term commencing March 28, 2027.

The Board has approved an aggregate commission of ₹60,00,000 for Independent Directors for FY26, constituting 0.18% of the net profit computed under Section 198 of the Companies Act, 2013. Approval is also sought for the annual payment of commission to non-executive directors, not exceeding 1% of net profits for five years from April 1, 2027, to March 31, 2032.

Remote e-voting will be available from Saturday, July 11, 2026, at 9:00 A.M. to Monday, July 13, 2026, at 5:00 P.M. The cut-off date for determining eligibility to vote via remote e-voting or at the AGM is Tuesday, July 7, 2026. Mr. Himanshu S. Kamdar of M/s. Rathi & Associates has been appointed as the scrutinizer.

In compliance with regulatory circulars, the Notice and Annual Report 2025-26 have been dispatched electronically to shareholders whose email IDs are registered with the company or its Registrar and Share Transfer Agent as of Friday, June 12, 2026. Physical copies will not be sent. The documents are available on the company’s website and stock exchange portals.

Key AGM Details

Agenda Item Details
Meeting Date July 14, 2026
Meeting Time 11:30 A.M. IST
Mode Video Conferencing / OAVM
Dividend ₹3.50 per share
Record Date June 29, 2026
Remote E-voting July 11, 2026 (9:00 A.M.) to July 13, 2026 (5:00 P.M.)
Voting Cut-off Date July 7, 2026

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+0.36%-1.90%-18.25%-41.72%+15.35%

How will the proposed 1% cap on non-executive director commissions for the next five years impact shareholder returns compared to the current 0.18% structure?

What strategic priorities will Mr. Ravi Razdan focus on following his re-appointment as Director-IT & HR to support the company's digital transformation?

Will the company maintain this dividend payout ratio in FY27, or are there plans to increase capital expenditure that could affect future distributions?

More News on Jyothy Laboratories

1 Year Returns:-41.72%